Getinge (GETI-B.ST)

Executive Summary

Getinge is a leading global medtech company headquartered in France, with a strong focus on lifesaving solutions in cardiovascular, surgical workflows, and intensive care. With over a century of history, the company provides innovative products including heart-lung machines, vascular grafts, and sterilization equipment. Getinge serves hospitals and healthcare providers worldwide, aiming to enhance patient outcomes and operational efficiency. The company is publicly traded on Nasdaq Stockholm (GETI-B.ST) with a market valuation around SEK 52 billion. Recently, Getinge has been investing in digital health and robotic-assisted surgery to sustain growth. Its diversified portfolio and recurring revenue from consumables and services provide resilience. However, margin pressures from raw material costs and regulatory hurdles in new product approvals remain key challenges. Overall, Getinge is well-positioned in the growing medical device market, driven by aging populations and rising healthcare demand.

Upcoming Catalysts (preview)

• Q3 2026FDA Approval of Next-Generation Heart-Lung Machine70% success
• Q3 2026Q2 2026 Earnings Beat on Strong Surgical Workflow Sales60% success
• TBDStrategic Acquisition in Robotic Surgery Space40% success